US 10106500
Selective androgen receptor modulators (SARMs) and uses thereof
granted A61KA61K31/401A61K31/402
Quick answer
US patent 10106500 (Selective androgen receptor modulators (SARMs) and uses thereof) held by Ligand Pharmaceuticals Incorporated expires Mon Oct 18 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ligand Pharmaceuticals Incorporated
- Grant date
- Tue Oct 23 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 18 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K31/401, A61K31/402, A61K31/5383, A61K45/06